| CEO Name | Don Zurbay |
| Nationality | United States |
| Net Worth Estimation | $15 million |
Don Zurbay's estimated net worth of around $15 million is primarily derived from his executive compensation, stock ownership, and long tenure at Patterson Companies, Inc. and previous roles at St. Jude Medical. His accumulated salary, bonuses, restricted stock awards, and option grants as CEO and CFO have significantly contributed to this valuation.
Don Zurbay, CEO of Patterson Companies, Inc., has an estimated net worth of $15,000,000, which is 6.25% above the minimum and 83.33% below the maximum CEO net worth in the healthcare sector. His net worth places him toward the lower end of the observed range for healthcare CEOs.
Business Category: Healthcare
Minimum Net Worth (estimation): 10000000 USD
Maximum Net Worth (estimation): 90000000 USD
Don Zurbay Performance in Patterson Companies, Inc.
Don Zurbay, CEO of Patterson Companies, Inc., demonstrates strategic leadership by driving innovation and operational efficiency in dental and animal health distribution. His decision-making focuses on data-driven growth initiatives and expanding digital capabilities, enhancing the company's competitive edge. Under Zurbay's leadership, Patterson Companies has improved financial performance and market position, solidifying its industry presence.
Latest News
Patterson Companies' Acquisition by Patient Square Capital and CEO Transition
In April 2025, Patterson Companies, a distributor for dental and animal health markets, was acquired by Patient Square Capital for approximately $4.1 billion, making Patterson a privately held company; former CEO Don Zurbay retired and Robert Rajalingam was appointed as the new CEO, bringing over 25 years of healthcare management experience. Shareholders approved the acquisition at a meeting, with the deal offering $31.35 per share in cash and aiming to accelerate growth and investment in customer service. Prior to this, Don Zurbay had led the company and recently sold shares under a trading plan in 2024, reflecting his ongoing stake during the transition.
Source: http://www.pattersoncompanies.com/news/patterson-companies-shareholders-approve-acquisition-by-patient-square-capital/